TITLE 16 OCCUPATIONAL AND PROFESSIONAL
LICENSING
CHAPTER 2 ACUPUNCTURE
AND ORIENTAL MEDICINE PRACTITIONERS
PART 20 EXPANDED
PRACTICE FORMULARY
16.2.20.1 ISSUING AGENCY: New
Mexico Board of Acupuncture and Oriental Medicine.
[16.2.20.1 NMAC - Rp/E,
16.2.20.1 NMAC, 06/15/2010; Re-pr, 11/28/10]
16.2.20.2 SCOPE: All doctors
of oriental medicine who are certified for expanded practice, or who are
enrolled in an educational course, or who are applicants for certification for
expanded practice, as well as all educational courses.
[16.2.20.2 NMAC - Rp/E,
16.2.20.2 NMAC, 06/15/2010; Re-pr, 11/28/10]
16.2.20.3 STATUTORY AUTHORITY: This
part is promulgated pursuant to the Acupuncture and Oriental Medicine Practice
Act, Section 61-14A-8.1 NMSA 1978.
[16.2.20.3 NMAC - Rp/E,
16.2.20.3 NMAC, 06/15/2010; Re-pr, 11/28/10]
16.2.20.4 DURATION: Permanent.
[16.2.20.4 NMAC - Rp/E,
16.2.20.4 NMAC, 06/15/2010; Re-pr, 11/28/10]
16.2.20.5 EFFECTIVE DATE: June
15, 2010
unless a later date is cited at the end of a section.
[16.2.20.5 NMAC - Rp/E,
16.2.20.5 NMAC, 06/15/2010; Re-pr, 11/28/10]
16.2.20.6 OBJECTIVE: This
part lists the formulary for each of the following expanded practice
certification categories: basic injection therapy, injection therapy,
intravenous therapy and bioidentical hormone therapy.
[16.2.20.6 NMAC - Rp/E,
16.2.20.6 NMAC, 06/15/2010; Re-pr, 11/28/10]
16.2.20.7 DEFINITIONS: [RESERVED]
16.2.20.8 EXPANDED
PRACTICE FORMULARIES GENERAL PROVISIONS: The following general
provisions shall apply to the expanded practice general formulary and each
specific formulary for each specific expanded practice category that follows in
this rule:
A. drugs, dangerous drugs and controlled substances are
defined in the New Mexico Drug, Device and Cosmetic Act and the New Mexico
Controlled Substances Act;
B. all substances from threatened or endangered species, as
determined by the convention on the international trade in endangered species
of wild fauna and flora and the U.S. fish and wildlife service (http://endangered.fws.gov/),
shall be automatically eliminated from expanded practice formularies;
C. definitions from the New Mexico Drug, Device and Cosmetic
Act and the New Mexico Controlled Substances Act apply to the appropriate terms
in the expanded practice formularies;
D. a doctor of oriental medicine shall comply with all
federal and state laws that pertain to obtaining, possessing, prescribing,
compounding, administering and dispensing any drug;
E. a substance shall only be approved for use if procured in compliance with all federal and state laws; the various expanded practice formularies do not supersede such laws; and
F. the following drugs, dangerous drugs and
controlled substances are authorized in the modes of administration that are
specified except as limited or restricted by federal or state law:
(1) basic
injection certification and prescriptive authority: shall include topical
vapocoolants the intradermal intramuscular, and subcutaneous injection of: homeopathic medicines; dextrose; enzymes except urokinase; hyaluronic
acid; minerals; sarapin; sodium
chloride; sterile water; and vitamins;
(2) injection
certification and prescriptive authority:
(a)
all substances from basic injection module; and
(b) all non-epidural, non
intrathecal injection of: alcohol, amino acids, autologous blood and blood
products and appropriate anticoagulant, live cell products, ozone, bee venom, beta glucans, caffeine collagenase,
dextrose, dimethyl sulfoxide, gammaglobulin, glucose, glucosamine, glycerin,
hyaluronidase, methylsulfonylmethane, phenol, phosphatidylcholine, procaine,
sodium hyaluronate, sodium morrhuate, therapeutic serum;
(3) intravenous
certification and prescriptive authority: amino acids, calcium
ethylenediaminetetraacetic acid, dextrose, glutathione, homeopathic medicines,
lactated ringers, minerals,
phosphatidylcholine, sodium bicarbonate sodium chloride, sodium morrhuate,
sterile water, water soluble vitamins, autologous blood and blood products with
appropriate anticoagulant, live cell products, ozone, and ultraviolet radiation
of blood with appropriate anticoagulant except that authority is not provided
for total parenteral nutrition;
(4) non-injectable
bioidentical hormone certification and prescriptive authority: 7-keto
dehydroepiandrosterone (7 keto DHEA), cortisone, dehydroepiandrosterone (DHEA),
dihydrotestosterone, estradiol (E2), estriol (E3), estrone (E1),
hydrocortisone, pregnenolone, progesterone, testosterone, tetraiodothyronine
(T4), levothyroxine, thyroxine (T4), & triiodothyronine (T3) combination,
triiodothyronine, liothyronine (T3), desiccated thyroid;
G. applicable to any of the four
certifications above: subcutaneous or intramuscular injection of epinephrine,
inhaled oxygen, and additives necessary to stabilize, preserve or balance pH of
approved substances.
[16.2.20.8 NMAC - Rp/E,
16.2.20.8 NMAC, 06/15/2010; Re-pr & A, 11/28/10; A, 02/08/13]
History of 16.2.20 NMAC:
History of Repealed Material:
16.2.20 NMAC, Expanded Practice Formulary (filed 10/29/2009) repealed 06/15/2010.
Other History:
16.2.20 NMAC, Expanded Practice Formulary (filed 10/29/2009) was replaced by 16.2.20 NMAC, Expanded Practice Formulary, effective 06/15/2010. This was an emergency filing that was necessary due to the courts reversing and setting aside the language effective on 11/28/2009.